Skip to content

Trauma-focused CBT Versus EMDR in the Treatment of Posttraumatic Stress Disorder

Trauma-focused CBT vs. EMDR in the Treatment of Posttraumatic Stress Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00716638
Enrollment
30
Registered
2008-07-16
Start date
2008-07-31
Completion date
2015-11-30
Last updated
2018-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Disorders, Post-Traumatic

Brief summary

This study will evaluate the effectiveness of trauma-focused cognitive behaviour therapy (TF-CBT) versus eye movement desensitization and reprocessing (EMDR) in the treatment of trauma survivors with post-traumatic stress disorder (PTSD). Patients will be randomly assigned to TF-CBT or EMDR. Follow-up assessments will be conducted at 3 and 12 months post-treatment. In addition to comparing the efficacy of the two protocols, an additional focus will lie on identifying predictors for treatment outcome.

Interventions

This intervention comprises 10 sessions of trauma-focused cognitive behavior therapy for PTSD with the components (a) prolonged imaginal exposure, (b) in vivo exposure, and (c) cognitive restructuring.

This intervention comprises 10 sessions of EMDR according to the standard protocol.

Sponsors

VU University of Amsterdam
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* A full diagnosis of PTSD according to the DSM-IV or subthreshold PTSD (criteria for intrusive re-experiencing are fulfilled and either three avoidance/numbing symptoms or two hyperarousal symptoms are present) * PTSD is related to one or more single-event traumas and participants have a clear memory of this event/these events (sufficient for constructing scenes to be used in exposure) * Age between 18 and 70 * Sufficient fluency in Dutch to complete treatment and research protocol * If participants are using anti-depressants, they need to be on a stable dose for at least 2 weeks before the beginning of treatment and remain on this dose throughout the treatment.

Exclusion criteria

* Dementia or other severe cognitive impairment * Psychosis * Depression with suicidal ideation * Bipolar disorder * Borderline Personality Disorder * Anti-social personality disorder * Substance dependence * Current use of tranquilizers * Exposure to prolonged and/or chronic trauma (type-II-trauma)

Design outcomes

Primary

MeasureTime frame
PTSD symptom severity: (a) interviewer rating (PSS-I); (b) self-report (PDS)Assessed at post-treatment, 3 months and 12 months follow-up

Secondary

MeasureTime frame
Depressive symptom severity (Beck Depression Inventory, BDI)assessed at post-treatment, 3 months and 12 months follow-up
Severity of anxiety symptoms (Beck Anxiety Inventory, BAI)assessed at posttreatment, 3 months and 12 months follow-up
Trauma-related appraisal (Posttraumatic Cognitions Inventory, PTCI)post-treatment

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026